title: Aflibercept-related sterile inflammation.
authors: Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, USA.
authors: Paul
authors: P
authors: Hahn
authors: Judy E
authors: JE
authors: Kim
authors: Sandra
authors: S
authors: Stinnett
authors: Mina M
authors: MM
authors: Chung
authors: Pravin U
authors: PU
authors: Dugel
authors: Harry W
authors: HW
authors: Flynn
authors: Suber S
authors: SS
authors: Huang
authors: Srinivas R
authors: SR
authors: Sadda
authors: Tamer H
authors: TH
authors: Mahmoud
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D056965:Injections, Intraocular; D008268:Macular Degeneration / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D040262:Receptors, Vascular Endothelial Growth Factor / Q000009:adverse effects*; D011993:Recombinant Fusion Proteins / Q000009:adverse effects*; D014605:Uveitis / Q000139:chemically induced*
chemical_list: D020533:Angiogenesis Inhibitors; D011993:Recombinant Fusion Proteins; C533178:aflibercept; D040262:Receptors, Vascular Endothelial Growth Factor